CDC Recommends First RSV Vaccines for Adults 60 and Older After Consultation With Doctors

RSV vaccines from Pfizer and GSK were approved for adults 60 and over but patients should discuss with doctors first before getting the single-dose shots.
The newly approved RSV vaccines are expected to be available this fall along with flu shots and COVID-19 boosters.
RSV kills thousands of older adults and hospitalizes tens of thousands each year, especially those with underlying health conditions.
The CDC initially considered recommending the shots for all adults 65 and up but softened guidance over concerns about effectiveness in frail patients, need for boosters and cost.
RSV caused a surge of infections in children last winter, straining hospitals in over 30 states.